Quantifying evidence for phenotypic specificity (PP4) for syndromic phenotypes: Large-scale integration of rare germline FH variants from diagnostic laboratory testing for HLRCC and renal cancer
Open Access
- 5 September 2025
- journal article
- Published by Elsevier in Genetics in Medicine
- Vol. 27 (11) , 101565
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Cancer Research UK
- NIHR Cambridge Biomedical Research Centre
This publication has 27 references indexed in Scilit:
- Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteriaThe American Journal of Human Genetics, 2022
- Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHDGenetics in Medicine, 2022
- Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelinesHuman Mutation, 2020
- Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancerCancer, 2020
- VariantValidator: Accurate validation, mapping, and formatting of sequence variation descriptionsHuman Mutation, 2017
- PERCH: A Unified Framework for Disease Gene PrioritizationHuman Mutation, 2016
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsThe American Journal of Human Genetics, 2016
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular TumoursEuropean Urology, 2016
- Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatmentFamilial Cancer, 2014
- LOVD v.2.0: the next generation in gene variant databasesHuman Mutation, 2011